Pays: Royaume-Uni
Langue: anglais
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Lanreotide acetate
Ipsen Ltd
H01CB03
Lanreotide acetate
200mg/1ml
Solution for injection
Subcutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 08030403; GTIN: 5036611000066